Skip to main content
Fig. 2 | Molecular Medicine

Fig. 2

From: The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma

Fig. 2

Exploration of the ARGs mutation and expression profiles in PRAD patients from the TCGA database. A cBioPortal oncoprint of ARGs mutation profiling in each PRAD patient. B Kaplan–Meier DFS curves of groups (log-rank test) with (N = 209) or without (N = 277) altered mutations. C cBioPortal oncoprint of ARGs expression profiling in each PRAD patient. D Kaplan–Meier DFS curves of groups (log-rank test) with altered expression of ARGs (N = 327) or not (N = 159)

Back to article page

Molecular Medicine

ISSN: 1528-3658